• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的动态模型,用于评估针对中央静脉导管细菌生物膜的抗菌活性。

A new dynamic model for evaluating antimicrobial activity against bacterial biofilms on central venous catheters.

机构信息

Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.

NMPA Key Laboratory for Safety Evaluation of Biomaterials and Medical Devices, Jinan, Shandong, China.

出版信息

Microbiol Spectr. 2024 Sep 3;12(9):e0023724. doi: 10.1128/spectrum.00237-24. Epub 2024 Jul 26.

DOI:10.1128/spectrum.00237-24
PMID:39058030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370253/
Abstract

Central venous catheters (CVCs) are widely used for intravenous medication administration. However, biofilm formation along the catheter surface is the main most important cause of catheter-related bloodstream infections. Nowadays, several antimicrobial-coated catheters are available to prevent biofilm development. In this study, we introduced a new dynamic model to evaluate the antimicrobial activity against bacterial biofilms on CVCs. Rifampicin-minocycline-coated catheters and control catheters without antimicrobial component were assembled into the model to test the antimicrobial activity on external surface and internal surface. After 1 h irrigation of or preculture and 23 h irrigation of Trypticase Soy Broth, the viable adherent organism was collected and counted. The enumeration results showed that the number of bacteria attached to antibacterial catheter was significantly less than that of the control catheter, both on external surface ( < 0.05) and internal surface ( < 0.05). The results were further confirmed by the scanning electron microscopy. In conclusion, the dynamic model can be applied to evaluate the antimicrobial activity against bacterial biofilms grown on the external and internal surfaces of CVCs used in clinical practice.IMPORTANCEFor the first time, a new dynamic model was constructed to evaluate the antimicrobial activity against bacterial biofilms on central venous catheters (CVCs) on both external surface and internal surface. This model could be applied to evaluate the antimicrobial activity against bacterial biofilms not only on CVCs but also other types of catheters.

摘要

中心静脉导管(CVC)广泛用于静脉内药物给药。然而,沿导管表面形成生物膜是导管相关性血流感染的主要原因。如今,有几种抗菌涂层导管可用于防止生物膜的发展。在这项研究中,我们引入了一种新的动态模型来评估对 CVC 上细菌生物膜的抗菌活性。利福平-米诺环素涂层导管和没有抗菌成分的对照导管被组装到模型中,以测试对外表面和内表面的抗菌活性。在 1 h 冲洗 或预培养物和 23 h 冲洗胰蛋白酶大豆肉汤后,收集并计数可存活的附着生物。计数结果表明,附着在抗菌导管上的细菌数量明显少于对照导管,无论是在外表面(<0.05)还是内表面(<0.05)。扫描电子显微镜进一步证实了这一结果。总之,该动态模型可用于评估临床实践中使用的 CVC 外部和内部表面上生长的细菌生物膜的抗菌活性。

重要性:
这是首次构建了一种新的动态模型来评估对 CVC 上细菌生物膜的抗菌活性,包括外表面和内表面。该模型不仅可用于评估 CVC 上的细菌生物膜的抗菌活性,还可用于评估其他类型导管上的抗菌活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/38f08fc18a72/spectrum.00237-24.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/fceba4755a75/spectrum.00237-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/59b737d601f1/spectrum.00237-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/2086e4acfd72/spectrum.00237-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/38f08fc18a72/spectrum.00237-24.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/fceba4755a75/spectrum.00237-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/59b737d601f1/spectrum.00237-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/2086e4acfd72/spectrum.00237-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5cc/11370253/38f08fc18a72/spectrum.00237-24.f004.jpg

相似文献

1
A new dynamic model for evaluating antimicrobial activity against bacterial biofilms on central venous catheters.一种新的动态模型,用于评估针对中央静脉导管细菌生物膜的抗菌活性。
Microbiol Spectr. 2024 Sep 3;12(9):e0023724. doi: 10.1128/spectrum.00237-24. Epub 2024 Jul 26.
2
Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.使用抗菌导管在更换导管期间预防多重耐药菌的传播。
Antimicrob Agents Chemother. 2014 Sep;58(9):5291-6. doi: 10.1128/AAC.02886-14. Epub 2014 Jun 23.
3
A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.一种使用新型装置和临床使用的导管评估抗菌活性对抗细菌生物膜的动态体外模型。
J Microbiol Methods. 2010 Dec;83(3):307-11. doi: 10.1016/j.mimet.2010.09.017. Epub 2010 Oct 1.
4
Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.利奈唑胺和万古霉素封管液添加与不添加肝素对产生物膜细菌的比较。
Am J Health Syst Pharm. 2017 May 1;74(9):e193-e201. doi: 10.2146/ajhp150804.
5
Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.具有广谱抗耐药菌和真菌活性的改良抗生素浸渍导管。
Antimicrob Agents Chemother. 2012 Feb;56(2):935-41. doi: 10.1128/AAC.05836-11. Epub 2011 Nov 28.
6
An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo.一种有机硒化合物可抑制体内血液透析导管上的金黄色葡萄球菌生物膜。
Antimicrob Agents Chemother. 2012 Feb;56(2):972-8. doi: 10.1128/AAC.05680-11. Epub 2011 Nov 28.
7
Development of X-ray micro-focus computed tomography to image and quantify biofilms in central venous catheter models in vitro.X射线微焦点计算机断层扫描技术的发展,用于体外中心静脉导管模型中生物膜的成像和定量分析。
Microbiology (Reading). 2016 Sep;162(9):1629-1640. doi: 10.1099/mic.0.000334. Epub 2016 Jul 6.
8
Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.持续释放一氧化氮的纳米颗粒在大鼠中心静脉导管模型中干扰耐甲氧西林金黄色葡萄球菌的黏附和生物膜形成。
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.02020-16. Print 2017 Jan.
9
Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against Clinical Isolates and Reference Strains.评价临床分离株和参考菌株在导尿管中的抗菌耐久性和抗生物膜效应。
Balkan Med J. 2017 Dec 1;34(6):546-552. doi: 10.4274/balkanmedj.2016.1853.
10
Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.替考拉宁与万古霉素封管液在清除中心静脉导管中产生物膜的葡萄球菌和肠球菌方面的比较。
Am J Health Syst Pharm. 2016 Mar 1;73(5):315-21. doi: 10.2146/ajhp150029.

引用本文的文献

1
Polymicrobial Biofilms: Interkingdom Interactions, Resistance and Therapeutic Strategies.多微生物生物膜:跨界相互作用、耐药性及治疗策略
Microb Biotechnol. 2025 Aug;18(8):e70218. doi: 10.1111/1751-7915.70218.

本文引用的文献

1
Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment.微生物生物膜:关于形成、感染、抗生素耐药性、控制措施及创新治疗的综述
Microorganisms. 2023 Jun 19;11(6):1614. doi: 10.3390/microorganisms11061614.
2
Biofilm and catheter-related bloodstream infections.生物膜与导管相关血流感染。
Br J Nurs. 2021 Apr 22;30(8):S4-S9. doi: 10.12968/bjon.2021.30.8.S4.
3
A Glance at Antimicrobial Strategies to Prevent Catheter-Associated Medical Infections.浅析预防导管相关性医疗感染的抗菌策略。
ACS Infect Dis. 2020 Dec 11;6(12):3109-3130. doi: 10.1021/acsinfecdis.0c00526. Epub 2020 Nov 27.
4
Methods for evaluating antimicrobial activity: A review.抗菌活性评估方法:综述
J Pharm Anal. 2016 Apr;6(2):71-79. doi: 10.1016/j.jpha.2015.11.005. Epub 2015 Dec 2.
5
Chitosan-based coatings in the prevention of intravascular catheter-associated infections.基于壳聚糖的涂层在预防血管内导管相关感染中的应用
J Biomater Appl. 2018 Jan;32(6):725-737. doi: 10.1177/0885328217739199. Epub 2017 Nov 7.
6
Chlorhexidine with or without alcohol against biofilm formation: efficacy, adverse events and taste preference.含或不含酒精的洗必泰对生物膜形成的影响:疗效、不良事件及口味偏好
Braz Oral Res. 2017 May 4;31:e32. doi: 10.1590/1807-3107BOR-2017.vol31.0032.
7
Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro.亚致死剂量的紫外线C光联合抗葡萄球菌抗生素对甲氧西林敏感和耐药的金黄色葡萄球菌及表皮葡萄球菌导管生物膜进行体外消毒的效果
Infect Drug Resist. 2016 Aug 19;9:181-9. doi: 10.2147/IDR.S109343. eCollection 2016.
8
Drug eluting antimicrobial vascular catheters: Progress and promise.载药抗菌血管导管:进展与前景。
Adv Drug Deliv Rev. 2017 Mar;112:35-47. doi: 10.1016/j.addr.2016.07.011. Epub 2016 Aug 2.
9
Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.重症监护病房中心静脉导管相关血流感染的减少与集束化依从性:一项全国性研究。
Infect Control Hosp Epidemiol. 2016 Jul;37(7):805-10. doi: 10.1017/ice.2016.67. Epub 2016 Apr 7.
10
Effectiveness of Minocycline/Rifampin vs Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters.米诺环素/利福平与洗必泰/磺胺嘧啶银浸渍中心静脉导管的有效性比较
J Am Coll Surg. 2015 Oct;221(4):891-2. doi: 10.1016/j.jamcollsurg.2015.07.004.